• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Avantis International Equity ETF (NY:AVDE)

73.24 -0.09 (-0.12%)
Official Closing Price Updated: 8:00 PM EDT, Aug 1, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 915,732
Open 73.33
Bid (Size) 69.07 (2)
Ask (Size) 77.41 (2)
Prev. Close 73.33
Today's Range 72.79 - 73.35
52wk Range 58.55 - 76.20
Shares Outstanding 894,500
Dividend Yield 3.41%
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Budweiser Maker’s Stock Gets Crushed After Q2 Gloom — Retail Traders Feel 'Drop Is A Bit Unjustified'
August 01, 2025
U.S.-listed shares of the world's largest brewer marked their worst day in over five years after the company missed revenue and volume estimates. 
Via Stocktwits
Topics Government
US Judge Upholds FDA Decision To Remove Wegovy, Ozempic From Shortage List In Move Against Compounding Pharmacies
June 18, 2025
The judge said that the FDA had appropriately weighed supply and demand data for the drugs and properly removed them from the shortage list, Reuters reported. 
Via Stocktwits
Topics Lawsuit

Performance

YTD
+19.5%
+19.5%
1 Month
-1.3%
-1.3%
3 Month
+4.8%
+4.8%
6 Month
+16.0%
+16.0%
1 Year
+19.1%
+19.1%

More News

Read More
Novo Nordisk’s Plan To Start Late-Stage Trial Of Investigational Obesity Drug Amycretin In 2026 Gets Retail Talking
June 12, 2025
Via Stocktwits
Novo Nordisk’s $812M Deal With Deep Apple Lifts Retail Mood, Chatter Spikes To High Levels
June 11, 2025
Via Stocktwits
Topics Artificial Intelligence Economy
Toyota Industries Likely To Accept $42B Takeover Bid From Toyota Motor And Group Companies, Says Report: Retail’s Undecided
June 02, 2025
Via Stocktwits
Topics Supply Chain
Toyota Records Fourth Straight Month Of Sales Jump In April: But Retail’s Not Yet Convinced
May 29, 2025
Via Stocktwits
Topics Government World Trade
Novo Nordisk To Sell Wegovy For $199 A Month As Compounding Ban Nears: Retail’s Bullish
May 22, 2025
Via Stocktwits
Novo Nordisk CEO Lars Jørgensen Steps Down Amid Challenges, Retail Chatter Spikes
May 16, 2025
Via Stocktwits
Budweiser Maker AB InBev Plans $300M Investment To Expand US Production: Retail Turns Bullish
May 13, 2025
Via Stocktwits
Topics Government
Toyota Expects 21% Profit Decline In FY26: Retail’s In Wait-And-Watch Mode
May 08, 2025
Via Stocktwits
Topics World Trade
Novo Nordisk Stock Rises Pre-Market On Q1 Beat Despite Lowering Outlook – Retail’s Elated
May 07, 2025
Via Stocktwits
Topics Earnings Law Enforcement
Why Is UBS Stock Trading Lower On Wednesday?
April 30, 2025
Via Benzinga
Novo Nordisk’s Weight-Loss Drug Wegovy Launched In Thailand, Marks Entry Into Southeast Asia
April 28, 2025
Via Stocktwits
Novo Nordisk Wins Another Legal Battle Against Compounding Of Wegovy, Ozempic: Retail’s Bullish
April 25, 2025
Via Stocktwits
Topics Lawsuit
Genmab Stock Rises On Strong Darzalex Sales In Q1: Retail Remains Extremely Bullish
April 15, 2025
Via Stocktwits
Topics Stocks
Novo Nordisk Warns Against Counterfeit Ozempic In US: Retail’s Unmoved
April 14, 2025
Via Stocktwits
Topics Economy
Novo Nordisk’s Controlling Shareholder Novo Holdings Reports Record Total Income, Investment Returns In 2024: Retail Stays Bullish
April 02, 2025
Via Stocktwits
Novo Nordisk Stock Slips After BofA, Morgan Stanley Slash Price Targets – But Retail Goes Contrarian
March 28, 2025
Via Stocktwits
Novo Nordisk Signs $2B Deal For Obesity Drug With Chinese Biotech: Retail Sentiment Improves
March 24, 2025
Via Stocktwits
Sony Stock Surges After Q3 Earnings Beat, Raised Outlook: Retail’s Not Convinced
February 14, 2025
Via Stocktwits
Topics Earnings
Sony Beats Q3 Earnings Expectations, PS5 And Streaming Revenues Growth Prompts Outlook Raise
February 13, 2025
Via Benzinga
Toyota Downgraded After Second Straight Profit Drop, But Stock Climbs As Annual Outlook Improves: Retail Stays Optimistic
February 05, 2025
Via Stocktwits
UBS Reports Strong Q4 Profit Growth, Warns Of Interest Income Decline
February 04, 2025
Via Benzinga
STMicroelectronics Q4 Earnings: 22% Revenue Drop, Sees Challenges With Lower Industrial and Auto Demand, Issues Weak Q1 Outlook
January 30, 2025
Via Benzinga
Sony Cancels Two Live-Service Games, Stays Committed to Long-Term Monetization
January 17, 2025
Via Benzinga

Frequently Asked Questions

Is Avantis International Equity ETF publicly traded?
Yes, Avantis International Equity ETF is publicly traded.
What exchange does Avantis International Equity ETF trade on?
Avantis International Equity ETF trades on the New York Stock Exchange
What is the ticker symbol for Avantis International Equity ETF?
The ticker symbol for Avantis International Equity ETF is AVDE on the New York Stock Exchange
What is the current price of Avantis International Equity ETF?
The current price of Avantis International Equity ETF is 73.24
When was Avantis International Equity ETF last traded?
The last trade of Avantis International Equity ETF was at 08/01/25 08:00 PM ET
What is the market capitalization of Avantis International Equity ETF?
The market capitalization of Avantis International Equity ETF is 65.51M
How many shares of Avantis International Equity ETF are outstanding?
Avantis International Equity ETF has 66M shares outstanding.
Site Logo
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap